AU1971799A - Peptide epitopes recognised by antifilaggrin autoantibodies in serum from rheumatoid arthritis patients - Google Patents

Peptide epitopes recognised by antifilaggrin autoantibodies in serum from rheumatoid arthritis patients

Info

Publication number
AU1971799A
AU1971799A AU19717/99A AU1971799A AU1971799A AU 1971799 A AU1971799 A AU 1971799A AU 19717/99 A AU19717/99 A AU 19717/99A AU 1971799 A AU1971799 A AU 1971799A AU 1971799 A AU1971799 A AU 1971799A
Authority
AU
Australia
Prior art keywords
serum
rheumatoid arthritis
peptide epitopes
arthritis patients
epitopes recognised
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU19717/99A
Inventor
Michel Arnaud
Pascal Dalbon
Elisabeth Girbal-Neuhauser
Michel Jolivet
Colette Jolivet-Reynaud
Mireille Sebbag
Guy Serre
Michel Simon
Christian Vincent
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Original Assignee
Biomerieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux SA filed Critical Biomerieux SA
Publication of AU1971799A publication Critical patent/AU1971799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Rehabilitation Therapy (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
AU19717/99A 1997-12-30 1998-12-29 Peptide epitopes recognised by antifilaggrin autoantibodies in serum from rheumatoid arthritis patients Abandoned AU1971799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9716673 1997-12-30
FR9716673A FR2773157B1 (en) 1997-12-30 1997-12-30 PEPTIDE EPITOPES RECOGNIZED BY ANTIFILAGGRIN AUTOANTIBODIES PRESENT IN THE SERUM OF PATIENTS WITH RHUMATOID POLYARTHRITIS
PCT/FR1998/002899 WO1999035167A1 (en) 1997-12-30 1998-12-29 Peptide epitopes recognised by antifilaggrin autoantibodies in serum from rheumatoid arthritis patients

Publications (1)

Publication Number Publication Date
AU1971799A true AU1971799A (en) 1999-07-26

Family

ID=9515272

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19717/99A Abandoned AU1971799A (en) 1997-12-30 1998-12-29 Peptide epitopes recognised by antifilaggrin autoantibodies in serum from rheumatoid arthritis patients

Country Status (5)

Country Link
EP (1) EP1042366A1 (en)
AU (1) AU1971799A (en)
CA (1) CA2316269A1 (en)
FR (1) FR2773157B1 (en)
WO (1) WO1999035167A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2773078B1 (en) * 1997-12-30 2000-05-26 Univ Toulouse USE OF CITRULLIN PEPTIDES DERIVED FROM FILAGGRIN FOR THE TREATMENT OF RHUMATOID POLYARTHRITIS
WO2001046222A2 (en) * 1999-12-21 2001-06-28 Innogenetics N.V. Peptides designed for the diagnosis and treatment of rheumatoid arthritis
FR2826124B1 (en) * 2001-06-13 2004-01-02 Bio Merieux METHOD FOR THE DETECTION OF RHUMATOID POLYARTHRITIS SPECIFIC SELF-ANTIBODIES
NL1019540C2 (en) * 2001-12-11 2003-07-01 Stichting Tech Wetenschapp Method for detecting autoantibodies from patients suffering from rheumatoid arthritis, peptide and assay kit.
CA2546312C (en) 2003-12-23 2010-11-09 Norbert Wild Method of assessing rheumatoid arthritis by measuring anti-ccp and interleukin 6
DK1721162T3 (en) 2004-02-27 2008-12-15 Hoffmann La Roche Method to assess rheumatoid arthritis by measuring anti-CCP and serum amyloid A
JP2010506147A (en) 2006-09-29 2010-02-25 エフ．ホフマン−ラ ロシュ アーゲー Risk assessment of disease progression for patients with rheumatoid arthritis
EP2336769A1 (en) 2009-12-18 2011-06-22 F. Hoffmann-La Roche AG Trigger assay for differentiating between rheumatic and non-rheumatic disorders
EP3056903A1 (en) 2015-02-13 2016-08-17 F. Hoffmann-La Roche AG Method of assessing rheumatoid arthritis by measuring anti-CCP and anti-Casp8
CN107484423A (en) 2015-02-13 2017-12-15 豪夫迈·罗氏有限公司 The method of rheumatoid arthritis is assessed by measuring anti-CCP and anti-PIK3CD
EP3056904A1 (en) 2015-02-13 2016-08-17 F. Hoffmann-La Roche AG Method of assessing rheumatoid arthritis by measuring anti-CCP and anti-MCM3

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2752842B1 (en) * 1996-08-30 1998-11-06 Biomerieux Sa ANTIGENS DERIVED FROM FILAGGRINS AND THEIR USE FOR THE DIAGNOSIS OF RHUMATOID POLYARTHRITIS

Also Published As

Publication number Publication date
FR2773157A1 (en) 1999-07-02
WO1999035167A1 (en) 1999-07-15
CA2316269A1 (en) 1999-07-15
FR2773157B1 (en) 2001-10-05
EP1042366A1 (en) 2000-10-11

Similar Documents

Publication Publication Date Title
AU1704099A (en) Monoclonal human natural antibodies
AU5752696A (en) Dna binding antibodies
AU1701001A (en) Antibodies against signal regulator proteins
IL128406A0 (en) Monoclonal antibodies
AU1462300A (en) Human pan-hcv human monoclonal antibodies
AU4042195A (en) Anti-alphaV-integrin monoclonal antibody
AU6868398A (en) Mu-opiate receptor peptides
EP0880597A4 (en) THERAPEUTIC APPLICATIONS FOR THE ANTI-T-BAM (CD40-L) MONOCLONAL ANTIBODY 5c8
AU6091494A (en) Igm-specific recombinant rheumatoid arthritis antigen
AU5181296A (en) Anti-obesity proteins
AU3667399A (en) Monoclonal antibodies specific for anthrax spores and peptides derived from the antibodies thereof
AU6702998A (en) Anti-alphabeta3 humanized monoclonal antibodies
AU1971799A (en) Peptide epitopes recognised by antifilaggrin autoantibodies in serum from rheumatoid arthritis patients
AU7247896A (en) Protein signature analysis
AU3587599A (en) Single chain monoclonal antibody fusion reagents that regulate transcript ion in vivo
WO1998057983A3 (en) Mammalian neuro-growth factor like protein
AU2645297A (en) Hepatitis b monoclonal antibodies
AU2576697A (en) Rheumatoid arthritis remedy containing anti-il-8 antibody as active ingredient
AU4375493A (en) Isolated protein receptors, antibodies which bind thereto, nucleic acid sequence coding therefor, and uses thereof
AU4524596A (en) Recombinant antigen for diagnosing rheumatoid arthritis
AU2596397A (en) Monoclonal antibody that detects apoptotic antigen
AU2452301A (en) Protein methylarginine-specific antibodies
AU4954796A (en) Monoclonal antibody specifically recognizing adeno-associated virus cap protein
AUPO957397A0 (en) Transporter protein
AU3670999A (en) Immunoassay with mixed peptides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase